744 related articles for article (PubMed ID: 27505171)
1. Accumulation of Advanced Glycation End Products Involved in Inflammation and Contributing to Severe Preeclampsia, in Maternal Blood, Umbilical Blood and Placental Tissues.
Chen W; Zhang Y; Yue C; Ye Y; Chen P; Peng W; Wang Y
Gynecol Obstet Invest; 2017; 82(4):388-397. PubMed ID: 27505171
[TBL] [Abstract][Full Text] [Related]
2. [Correlation of the expressions of advanced glycation end products and its receptor in serum and placenta with the pathogenesis of preeclampsia].
Xian N; Chen W; Zhang Y; Li J; Zhang N; Ye Y
Zhonghua Fu Chan Ke Za Zhi; 2015 Jul; 50(7):493-9. PubMed ID: 26311638
[TBL] [Abstract][Full Text] [Related]
3. Activation of the receptor for advanced glycation end products system in women with severe preeclampsia.
Oliver EA; Buhimschi CS; Dulay AT; Baumbusch MA; Abdel-Razeq SS; Lee SY; Zhao G; Jing S; Pettker CM; Buhimschi IA
J Clin Endocrinol Metab; 2011 Mar; 96(3):689-98. PubMed ID: 21325454
[TBL] [Abstract][Full Text] [Related]
4. JNK and ATF4 as two important platforms for tumor necrosis factor-α-stimulated shedding of receptor for advanced glycation end products.
Miyoshi A; Koyama S; Sasagawa-Monden M; Kadoya M; Konishi K; Shoji T; Inaba M; Yamamoto Y; Koyama H
FASEB J; 2019 Mar; 33(3):3575-3589. PubMed ID: 30452882
[TBL] [Abstract][Full Text] [Related]
5. Expression of advanced glycation end products in placenta and concentration in maternal and umbilical serum in pre-eclampsia.
Yan JY; Jiang LL
J Obstet Gynaecol Res; 2015 Jun; 41(6):843-9. PubMed ID: 25656432
[TBL] [Abstract][Full Text] [Related]
6. Placental Proinflammatory State and Maternal Endothelial Dysfunction in Preeclampsia.
Valencia-Ortega J; Zárate A; Saucedo R; Hernández-Valencia M; Cruz JG; Puello E
Gynecol Obstet Invest; 2019; 84(1):12-19. PubMed ID: 30007972
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of sRAGE on fetal development in pregnant rats with gestational diabetes mellitus.
Tang X; Qin Q; Xie X; He P
Cell Biochem Biophys; 2015 Mar; 71(2):549-56. PubMed ID: 25205260
[TBL] [Abstract][Full Text] [Related]
8. Differential Receptor for Advanced Glycation End Products Expression in Preeclamptic, Intrauterine Growth Restricted, and Gestational Diabetic Placentas.
Alexander KL; Mejia CA; Jordan C; Nelson MB; Howell BM; Jones CM; Reynolds PR; Arroyo JA
Am J Reprod Immunol; 2016 Feb; 75(2):172-80. PubMed ID: 26682535
[TBL] [Abstract][Full Text] [Related]
9. Fructose causes endothelial cell damage via activation of advanced glycation end products-receptor system.
Sotokawauchi A; Matsui T; Higashimoto Y; Yamagishi SI
Diab Vasc Dis Res; 2019 Nov; 16(6):556-561. PubMed ID: 31375034
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory processes are specifically enhanced in endothelial cells by placental-derived TNF-α: Implications in preeclampsia (PE).
Shaw J; Tang Z; Schneider H; Saljé K; Hansson SR; Guller S
Placenta; 2016 Jul; 43():1-8. PubMed ID: 27324092
[TBL] [Abstract][Full Text] [Related]
11. Age-related accumulation of advanced glycation end-products-albumin, S100β, and the expressions of advanced glycation end product receptor differ in visceral and subcutaneous fat.
Son KH; Son M; Ahn H; Oh S; Yum Y; Choi CH; Park KY; Byun K
Biochem Biophys Res Commun; 2016 Aug; 477(2):271-6. PubMed ID: 27301641
[TBL] [Abstract][Full Text] [Related]
12. Modulation of high sensitivity C-reactive protein by soluble receptor for advanced glycation end products.
McNair ED; Wells CR; Mabood Qureshi A; Basran R; Pearce C; Orvold J; Devilliers J; Prasad K
Mol Cell Biochem; 2010 Aug; 341(1-2):135-8. PubMed ID: 20339904
[TBL] [Abstract][Full Text] [Related]
13. [Interaction among abnormal fatty acid oxidation, endothelial function disorder, and oxidative stress in the onset of severe preeclampsia].
Wang JL; Yang Z; Wang R; Zhu JM
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(21):1471-5. PubMed ID: 18953853
[TBL] [Abstract][Full Text] [Related]
14. Shixiang Plaster, a Traditional Chinese Medicine, Promotes Healing in a Rat Model of Diabetic Ulcer Through the receptor for Advanced Glycation End Products (RAGE)/Nuclear Factor kappa B (NF-κB) and Vascular Endothelial Growth Factor (VEGF)/Vascular Cell Adhesion Molecule-1 (VCAM-1)/Endothelial Nitric Oxide Synthase (eNOS) Signaling Pathways.
Fei J; Ling YM; Zeng MJ; Zhang KW
Med Sci Monit; 2019 Dec; 25():9446-9457. PubMed ID: 31825949
[TBL] [Abstract][Full Text] [Related]
15. Maternal and umbilical serum levels of interleukin-6, interleukin-8, and tumor necrosis factor-alpha in normal pregnancies and in pregnancies complicated by preeclampsia.
Tosun M; Celik H; Avci B; Yavuz E; Alper T; Malatyalioğlu E
J Matern Fetal Neonatal Med; 2010 Aug; 23(8):880-6. PubMed ID: 20441409
[TBL] [Abstract][Full Text] [Related]
16. Endothelial cell expression of adhesion molecules is induced by fetal plasma from pregnancies with umbilical placental vascular disease.
Wang X; Athayde N; Trudinger B
BJOG; 2002 Jul; 109(7):770-7. PubMed ID: 12135213
[TBL] [Abstract][Full Text] [Related]
17. Analysis of changes in high-mobility group box 1, receptor for advanced glycation endproducts, and T helper 17/regulatory T balance in severe preeclampsia with acute heart failure.
De C; Xuan L; Jingjing Z; Honghong Z; Kun Z; Song D; Yaqi S; Ying J; Cheng C; Jian L
J Clin Hypertens (Greenwich); 2024 Apr; 26(4):431-440. PubMed ID: 38523455
[TBL] [Abstract][Full Text] [Related]
18. [Expression and significance of heat shock protein 70 in maternal serum, umbilical cord blood and placenta of patients with hypertensive disorders complicating pregnancy].
Zhu J; Li M; Li L
Zhonghua Fu Chan Ke Za Zhi; 2014 Sep; 49(9):676-80. PubMed ID: 25487454
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Interventions for Advanced Glycation-End Products and its Receptor- Mediated Cardiovascular Disease.
Prasad K; Tiwari S
Curr Pharm Des; 2017; 23(6):937-943. PubMed ID: 27719648
[TBL] [Abstract][Full Text] [Related]
20. Association between Advanced Glycation End Products, Soluble RAGE Receptor, and Endothelium Dysfunction, Evaluated by Circulating Endothelial Cells and Endothelial Progenitor Cells in Patients with Mild and Resistant Hypertension.
Gryszczyńska B; Budzyń M; Begier-Krasińska B; Osińska A; Boruczkowski M; Kaczmarek M; Bukowska A; Iskra M; Kasprzak MP
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
